Continuous Peripheral Nerve Block Catheter Market Exhibits a Stunning Growth Potentials | B. Braun Melsungen AG, Teleflex Incorporated & Halyard Health

 The growing senior population is driving up the demand for postoperative pain management solutions, which is driving up the volume of orthopaedic procedures. Furthermore, in major orthopaedic procedures, cPNBs are rapidly replacing traditional regional anaesthetic approaches. One of the primary factors is the growing amount of surgeries combined with the growing requirement for adequate postoperative care. In 2017, the global continuous peripheral nerve block catheter market catheters were valued at USD 181.4 million. Over the forecast period, it is expected to grow at a CAGR of 6.2 per cent.

The increased prevalence of osteoarthritis, the most common joint condition, has resulted in an increase in the number of joint replacements and arthroplasties during the last decade. According to the International Association for the Study of Pain, symptomatic osteoarthritis affected between 10% to 15% of the global population in 2016. The world's population is ageing, and the prevalence of osteoarthritis is rising, which is contributing to an increase in the number of orthopaedic surgery.

CPNB catheters are also useful in the event of amputation of a major limb. A considerable majority of cases include lower extremity amputations due to diabetic foot ulceration. The International Diabetes Federation estimates that the global diabetes population will grow from 424.9 million in 2017 to 628.6 million in 2045. Across the globe, the number of amputations is on the rise.

Patients who have had joint replacements or arthroplasties, as well as limb amputations, commonly endure post-operative discomfort. After ambulatory surgery, around a third of patients report moderate to severe postoperative discomfort. The use of long-acting opioids to combat this has been linked to a variety of side effects, including nausea, vomiting, and constipation.

Using cPNB catheters for regional anaesthetic, on the other hand, results in superior post-surgical outcomes and reduces long-acting opioid side effects. As a result, the general increase of catheters is being accelerated by a declining preference for opiate use in pain management.

In 2017, North America had the greatest share, valued at USD 96.3 million. This is due to a larger target population as well as an increase in the prevalence of lifestyle-related disorders such as diabetes and orthopaedic ailments. A well-developed reimbursement framework and an increasing number of day-care surgery centres are also contributing to total income production. The European Society of Regional Anaesthesia and Pain Therapy (ESRA) advises using peripheral nerve blocks for acute postoperative pain in both adults and children, with the latter obtaining a larger percentage of cPNBs. A growth in daycare/ambulatory procedures across the region is also helping to drive the usage of these devices.

The market is fiercely competitive, with a small number of competitors controlling the vast majority of the market share. B. Braun Melsungen AG, Teleflex Incorporated, Halyard Health, Inc., Pajunk GMBH, and Vygon are among the notable participants.